These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. Schuetz EG, Umbenhauer DR, Yasuda K, Brimer C, Nguyen L, Relling MV, Schuetz JD, Schinkel AH. Mol Pharmacol; 2000 Jan; 57(1):188-97. PubMed ID: 10617694 [Abstract] [Full Text] [Related]
8. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S. Biochemistry; 1998 Mar 17; 37(11):3594-601. PubMed ID: 9530286 [Abstract] [Full Text] [Related]
9. Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1. Findling-Kagan S, Sivan H, Ostrovsky O, Nagler A, Galski H. Leuk Res; 2005 Apr 17; 29(4):407-14. PubMed ID: 15725475 [Abstract] [Full Text] [Related]
10. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein. Kang CD, Ahn BK, Jeong CS, Kim KW, Lee HJ, Yoo SD, Chung BS, Kim SH. Exp Cell Res; 2000 Apr 10; 256(1):300-7. PubMed ID: 10739677 [Abstract] [Full Text] [Related]
11. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport. Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Sharma V. Dalton Trans; 2010 Jul 07; 39(25):5842-50. PubMed ID: 20505882 [Abstract] [Full Text] [Related]
12. Structural and functional characterization of the mouse multidrug resistance gene family. Dhir R, Buschman E, Gros P. Bull Cancer; 1990 Jul 07; 77(11):1125-9. PubMed ID: 1980424 [Abstract] [Full Text] [Related]
13. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Pichler A, Zelcer N, Prior JL, Kuil AJ, Piwnica-Worms D. Clin Cancer Res; 2005 Jun 15; 11(12):4487-94. PubMed ID: 15958634 [Abstract] [Full Text] [Related]
14. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein. Maki N, Moitra K, Silver C, Ghosh P, Chattopadhyay A, Dey S. Biochemistry; 2006 Feb 28; 45(8):2739-51. PubMed ID: 16489767 [Abstract] [Full Text] [Related]
15. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein. Buschman E, Gros P. Cancer Res; 1994 Sep 15; 54(18):4892-8. PubMed ID: 7915194 [Abstract] [Full Text] [Related]
16. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Biochem Pharmacol; 2002 Aug 15; 64(4):573-82. PubMed ID: 12167476 [Abstract] [Full Text] [Related]
17. Biochemical basis of polyvalency as a strategy for enhancing the efficacy of P-glycoprotein (ABCB1) modulators: stipiamide homodimers separated with defined-length spacers reverse drug efflux with greater efficacy. Sauna ZE, Andrus MB, Turner TM, Ambudkar SV. Biochemistry; 2004 Mar 02; 43(8):2262-71. PubMed ID: 14979722 [Abstract] [Full Text] [Related]
18. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R. Planta Med; 2006 Jun 02; 72(7):634-9. PubMed ID: 16739070 [Abstract] [Full Text] [Related]
19. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin. Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R. Cancer Chemother Pharmacol; 2005 Aug 02; 56(2):173-81. PubMed ID: 15824923 [Abstract] [Full Text] [Related]